Investigating Electroencephalographic Predictors of Default Mode Network Anticorrelation in Healthy Adults
Launched by DREXEL UNIVERSITY · Oct 21, 2022
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how certain brain activities are connected to attention in healthy adults. Participants will take part in two sessions where researchers will measure brain activity using special techniques called electroencephalography (EEG) and functional Magnetic Resonance Imaging (fMRI). In the first session, participants will complete tasks that test their attention while their brain activity is recorded. In the second session, they will receive real-time feedback on their brain activity and try to control it, helping researchers learn more about how the brain works.
To be eligible for this study, participants must be between 18 and 35 years old and should not have any history of psychiatric or neurological disorders. They also need to be able to undergo an MRI scan safely. This trial is currently recruiting participants, and it offers a unique opportunity to explore how our brains function during attention tasks while also learning to influence brain activity through feedback.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18-35
- Exclusion Criteria:
- • History of psychiatric or neurological disorder
- • contraindication for MRI
About Drexel University
Drexel University is a prominent research institution located in Philadelphia, Pennsylvania, known for its commitment to advancing knowledge through innovative research and education. As a clinical trial sponsor, Drexel University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving health outcomes. The university fosters collaborations across various fields, including medicine, engineering, and public health, ensuring a comprehensive approach to addressing complex health challenges. With a focus on ethical standards and participant safety, Drexel University is dedicated to translating research findings into practical applications that enhance community well-being and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials